Home / Companies / Vertex Pharmaceuticals Incorporated / 13 May 2026
Vertex Pharmaceuticals Incorporated: meeting of 13 May 2026
Votes reported on Form N-PX, item by item
1,509 Form N-PX filers reported votes at the Vertex Pharmaceuticals Incorporated meeting of 13 May 2026. Their records fall into 6 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
10 nominees; 93.9% of reported votes for; 99 filers withheld from or voted against at least one nominee.
11,737 vote records from 400 filers. 5 of the 399 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
2,570 vote records from 1,494 filers. 98 of the 1,452 filers that marked the item either way voted against management. 42 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
1,139 vote records from 399 filers. 6 of the 398 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
1,189 vote records from 407 filers. 14 of the 404 filers that marked the item either way voted against management. 3 filers reported this item without a management mark.
CORPORATE GOVERNANCESecurity holder
Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written...
1,089 vote records from 382 filers. 200 of the 382 filers that marked the item either way voted against management.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
22 vote records from 13 filers. 7 of the 11 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor | 5. Proposal |
|---|---|---|---|---|
| Vanguard | For | For | For | Against |
| BlackRock and iShares | For | For | For | Against |
| Fidelity | For | For | For | Against |
| Dimensional | For | For | For | Against |
| State Street and SPDR | For | For | For | Against |
| American Century | For | For | For | Against |
| Franklin Templeton | For | For | For | For * |
| Invesco | For | For | For | For * |
| Equitable | For | For | For | For * |
| Charles Schwab | For | For | For | Against |
| Nuveen and TIAA | For | For | For | Against |
| ProShares and ProFunds | For | For | For | For * |
| John Hancock and Manulife | For | For | For | For * |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For | For * |
| J.P. Morgan | For | For | For | Against |
| Goldman Sachs | For | For | For | Against |
| WisdomTree | For | For | For | For * |
| PGIM and Prudential | For | For | For | Against |
| Jackson National funds | For | For | For | For * |
| Northern Trust and FlexShares | For | For | For | Against |
| SEI | For | For | For | For * |
| T. Rowe Price | For | For | For | Against |
| Thrivent | For | For | For | Against |
| Lincoln Financial | For | For | For | For * |
| Voya | For | For | For | Against |
| First Trust | For | For | For | For * |
| Russell Investments | For | For | For | For * |
| Nationwide | For | For | For | Against |
| Victory Capital | For | For | For | For * |
| Brighthouse Funds | For | For | For | Against |
| Guggenheim and Rydex | For | For | For | For * |
| Columbia Threadneedle | For | For | For | For * |
| BNY Mellon | For | For | For | For * |
| Principal | For | For | For | Against |
| Capital Group and American Funds | For | For | For | For * |
| Pacific Life funds | For | For | For | Against |
| Global X | For | For | For | For * |
| MFS | For | For | For | For * |
| Transamerica | For | For | For | For * |
| Federated Hermes | For | For | For | Against |
| AllianceBernstein | For | For | For | For * |
| Hartford Funds | For | For | For | For * |
| DWS | For | Against * | For | For * |
| PIMCO | For | For | For | For * |
| Allspring | For | For | For | Against |
| MassMutual | For | For | For | Against |
| Harbor Funds | For | For | For | Against |
| Virtus | For | For | For | For * |
| VanEck | For | For | For | For * |
| Macquarie and Delaware Funds | For | For | For | For * |
| Janus Henderson | For | For | For | Against |
| Neuberger Berman | For | For | For | Against |
| Natixis and Loomis Sayles | For | For | For | Against |
| Lord Abbett | For | For | For | Against |
| Baird | No report | For | No report | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Vertex Pharmaceuticals Incorporated meeting?
1,509 Form N-PX filers reported votes at the meeting of 13 May 2026. On say-on-pay, 98 of 1,452 voted against management (6.7%). One proposal from security holders could be told apart in the filings. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Vertex Pharmaceuticals Incorporated on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Vertex Pharmaceuticals Incorporated
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Vertex Pharmaceuticals Incorporated with a meeting date within three days of 13 May 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.